Andrew R Allen - Net Worth and Insider Trading
Andrew R Allen Net Worth
The estimated net worth of Andrew R Allen is at least $2 Million dollars as of 2024-05-28. Andrew R Allen is the PRESIDENT AND CEO of Gritstone Bio Inc and owns about 2,434,635 shares of Gritstone Bio Inc (GRTS) stock worth over $2 Million. Andrew R Allen is the Director of Sierra Oncology Inc and owns about 1,650 shares of Sierra Oncology Inc (SRRA) stock worth over $90,734. Andrew R Allen is also the See Remarks of Clovis Oncology Inc and owns about 181,919 shares of Clovis Oncology Inc (CLVSQ) stock worth over $2,729. Details can be seen in Andrew R Allen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Andrew R Allen has not made any transactions after 2024-05-16 and currently still holds the listed stock(s).
Transaction Summary of Andrew R Allen
Andrew R Allen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew R Allen owns 6 companies in total, including Sierra Oncology Inc (SRRA) , Epizyme Inc (EPZM) , and Gritstone Bio Inc (GRTS) among others .
Click here to see the complete history of Andrew R Allen’s form 4 insider trades.
Insider Ownership Summary of Andrew R Allen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SRRA | Sierra Oncology Inc | 2018-12-10 | director |
| EPZM | Epizyme Inc | 2019-05-31 | director |
| GRTS | Gritstone Bio Inc | 2024-05-16 | director & President and CEO |
 | | 2019-02-13 | director |
| | 2013-06-05 | SEE REMARKS |
| | 2023-06-01 | director |
Andrew R Allen Latest Holdings Summary
Andrew R Allen currently owns a total of 3 stocks. Among these stocks, Andrew R Allen owns 2,434,635 shares of Gritstone Bio Inc (GRTS) as of May 16, 2024, with a value of $2 Million and a weighting of 95.43%. Andrew R Allen owns 1,650 shares of Sierra Oncology Inc (SRRA) as of December 10, 2018, with a value of $90,734 and a weighting of 4.44%. Andrew R Allen also owns 181,919 shares of Clovis Oncology Inc (CLVSQ) as of June 5, 2013, with a value of $2,729 and a weighting of 0.13%.
Latest Holdings of Andrew R Allen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GRTS | Gritstone Bio Inc | 2024-05-16 | 2,434,635 | 0.80 | 1,951,603 |
| SRRA | Sierra Oncology Inc | 2018-12-10 | 1,650 | 54.99 | 90,734 |
| CLVSQ | Clovis Oncology Inc | 2013-06-05 | 181,919 | 0.02 | 2,729 |
Holding Weightings of Andrew R Allen
Andrew R Allen Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew R Allen has made a total of 1 transactions in Gritstone Bio Inc (GRTS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Gritstone Bio Inc is the sale of 24,263 shares on May 16, 2024, which brought Andrew R Allen around $18,197.
According to the SEC Form 4 filings, Andrew R Allen has made a total of 0 transactions in Sierra Oncology Inc (SRRA) over the past 5 years. The most-recent trade in Sierra Oncology Inc is the acquisition of 1,650 shares on December 10, 2018, which cost Andrew R Allen around $108,240.
According to the SEC Form 4 filings, Andrew R Allen has made a total of 0 transactions in Clovis Oncology Inc (CLVSQ) over the past 5 years. The most-recent trade in Clovis Oncology Inc is the sale of 22,594 shares on June 5, 2013, which brought Andrew R Allen around $2 Million.
Insider Trading History of Andrew R Allen
- 1
Andrew R Allen Trading Performance
GuruFocus tracks the stock performance after each of Andrew R Allen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew R Allen is 54%. GuruFocus also compares Andrew R Allen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew R Allen within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andrew R Allen's insider trading performs compared to the benchmark.
Performance of Andrew R Allen
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.22 | | | | | |
| Relative Return to S&P 500(%) | -1.13 | | | | | |
Andrew R Allen Ownership Network
Andrew R Allen Owned Company Details
What does Sierra Oncology Inc do?
Who are the key executives at Sierra Oncology Inc?
Andrew R Allen is the director of Sierra Oncology Inc. Other key executives at Sierra Oncology Inc include director & 10 percent owner Vivo Opportunity Fund Holdings, L.p. , Chief Reg & Tech Ops Officer William D. Turner , and General Counsel Mary Christina Thomson .
Sierra Oncology Inc (SRRA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sierra Oncology Inc (SRRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sierra Oncology Inc (SRRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sierra Oncology Inc (SRRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sierra Oncology Inc Insider Transactions
Andrew R Allen Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew R Allen. You might contact Andrew R Allen via mailing address: 2525 28th Street, Suite 200, Boulder Co 80301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
